• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性创伤性脑病:诊断的更新与进展

Chronic traumatic encephalopathy: Diagnostic updates and advances.

作者信息

Pierre Kevin, Molina Vanessa, Shukla Shil, Avila Anthony, Fong Nicholas, Nguyen Jessica, Lucke-Wold Brandon

机构信息

University of Florida Department of Radiology, Gainesville 32603, Florida, USA.

Sam Houston State University of Osteopathic Medicine, Conroe 77304, Texas, USA.

出版信息

AIMS Neurosci. 2022 Dec 19;9(4):519-535. doi: 10.3934/Neuroscience.2022030. eCollection 2022.

DOI:10.3934/Neuroscience.2022030
PMID:36660076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9826753/
Abstract

Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease that occurs secondary to repetitive mild traumatic brain injury. Current clinical diagnosis relies on symptomatology and structural imaging findings which often vary widely among those with the disease. The gold standard of diagnosis is post-mortem pathological examination. In this review article, we provide a brief introduction to CTE, current diagnostic workup and the promising research on imaging and fluid biomarker diagnostic techniques. For imaging, we discuss quantitative structural analyses, DTI, fMRI, MRS, SWI and PET CT. For fluid biomarkers, we discuss p-tau, TREM2, CCL11, NfL and GFAP.

摘要

慢性创伤性脑病(CTE)是一种继发于重复性轻度创伤性脑损伤的进行性神经退行性疾病。目前的临床诊断依赖于症状学和结构影像学检查结果,而这些在患有该疾病的患者中往往差异很大。诊断的金标准是死后病理检查。在这篇综述文章中,我们简要介绍了CTE、当前的诊断检查以及关于影像学和液体生物标志物诊断技术的前沿研究。对于影像学,我们讨论了定量结构分析、弥散张量成像(DTI)、功能磁共振成像(fMRI)、磁共振波谱(MRS)、磁敏感加权成像(SWI)和正电子发射断层扫描(PET CT)。对于液体生物标志物,我们讨论了磷酸化tau蛋白(p-tau)、触发受体表达于髓样细胞2(TREM2)、趋化因子配体11(CCL11)、神经丝轻链(NfL)和胶质纤维酸性蛋白(GFAP)。

相似文献

1
Chronic traumatic encephalopathy: Diagnostic updates and advances.慢性创伤性脑病:诊断的更新与进展
AIMS Neurosci. 2022 Dec 19;9(4):519-535. doi: 10.3934/Neuroscience.2022030. eCollection 2022.
2
The diagnostic potential of fluid and imaging biomarkers in chronic traumatic encephalopathy (CTE).流体和成像生物标志物在慢性创伤性脑病(CTE)中的诊断潜力。
Biomed Pharmacother. 2022 Feb;146:112602. doi: 10.1016/j.biopha.2021.112602. Epub 2022 Jan 4.
3
Chronic Traumatic Encephalopathy: A Comprehensive Narrative Review of Its Biomarkers.慢性创伤性脑病:其生物标志物的全面叙述性综述
Cureus. 2024 Sep 16;16(9):e69510. doi: 10.7759/cureus.69510. eCollection 2024 Sep.
4
Sports-related brain injuries: connecting pathology to diagnosis.与运动相关的脑损伤:将病理学与诊断联系起来。
Neurosurg Focus. 2016 Apr;40(4):E14. doi: 10.3171/2016.1.FOCUS15607.
5
Chronic Traumatic Encephalopathy: The cellular sequela to repetitive brain injury.慢性创伤性脑病:重复性脑损伤的细胞后遗症。
J Clin Neurosci. 2017 Jul;41:24-29. doi: 10.1016/j.jocn.2017.03.035. Epub 2017 Mar 27.
6
Traumatic brain injury (TBI) in collision sports: Possible mechanisms of transformation into chronic traumatic encephalopathy (CTE).颅脑创伤(TBI)在碰撞性运动中:转变为慢性创伤性脑病(CTE)的可能机制。
Metabolism. 2019 Nov;100S:153943. doi: 10.1016/j.metabol.2019.07.007.
7
Rationale and design of the "NEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)" study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathy.“神经退行性变:创伤性脑损伤作为神经病理学起源(新视野)”研究的原理和设计:慢性创伤性脑病风险个体的前瞻性队列研究。
Alzheimers Res Ther. 2022 Sep 1;14(1):119. doi: 10.1186/s13195-022-01059-8.
8
Chronic Traumatic Encephalopathy: The Impact on Athletes.慢性创伤性脑病:对运动员的影响
Cureus. 2016 Mar 14;8(3):e532. doi: 10.7759/cureus.532.
9
Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward.正电子发射断层扫描/计算机断层扫描在慢性创伤性脑病中的神经影像学研究:核医学如何推动该领域的发展。
Expert Rev Mol Diagn. 2022 Feb;22(2):149-156. doi: 10.1080/14737159.2022.2035723. Epub 2022 Feb 2.
10
Chronic Traumatic Encephalopathy in Athletes Involved with High-impact Sports.从事高强度运动的运动员的慢性创伤性脑病
J Vasc Interv Neurol. 2016 Oct;9(2):34-48.

引用本文的文献

1
Does white matter and vascular injury from repetitive head impacts lead to a novel pattern on T2 FLAIR MRI? A hypothesis proposal and call for research.重复性头部撞击导致的白质和血管损伤会在T2 FLAIR磁共振成像上呈现出一种新的模式吗?一项假设提议及研究呼吁。
Alzheimers Dement. 2025 Mar;21(3):e70085. doi: 10.1002/alz.70085.
2
Beyond the Hit: The Hidden Costs of Repetitive Head Trauma.创伤之外:重复性头部创伤的隐性代价
Neurosci Insights. 2025 Feb 3;20:26331055251316315. doi: 10.1177/26331055251316315. eCollection 2025.
3
Fluid biomarkers of chronic traumatic brain injury.慢性创伤性脑损伤的液体生物标志物。
Nat Rev Neurol. 2024 Nov;20(11):671-684. doi: 10.1038/s41582-024-01024-z. Epub 2024 Oct 3.
4
Neutrophil-Lymphocytes Ratio as Potential Early Marker for Alzheimer's Disease.中性粒细胞与淋巴细胞比值可作为阿尔茨海默病的早期潜在标志物。
Mediators Inflamm. 2024 Jun 30;2024:6640130. doi: 10.1155/2024/6640130. eCollection 2024.
5
White and gray matter integrity evaluated by MRI-DTI can serve as noninvasive and reliable indicators of structural and functional alterations in chronic neurotrauma.MRI-DTI 评估的白质和灰质完整性可以作为慢性神经创伤结构和功能改变的无创可靠指标。
Sci Rep. 2024 Mar 27;14(1):7244. doi: 10.1038/s41598-024-57706-7.
6
Editorial: Human brain banking - Bridging brain health and precision neurology.社论:人类脑库——连接脑健康与精准神经病学
Front Neurol. 2023 Oct 27;14:1322200. doi: 10.3389/fneur.2023.1322200. eCollection 2023.
7
Blood-Based Biomarkers in the Diagnosis of Chronic Traumatic Encephalopathy: Research to Date and Future Directions.基于血液的生物标志物在慢性创伤性脑病诊断中的应用:现有研究与未来方向。
Int J Mol Sci. 2023 Aug 8;24(16):12556. doi: 10.3390/ijms241612556.

本文引用的文献

1
Longitudinal changes of white matter microstructure following traumatic brain injury in U.S. military service members.美国军人创伤性脑损伤后白质微结构的纵向变化。
Brain Commun. 2022 May 27;4(3):fcac132. doi: 10.1093/braincomms/fcac132. eCollection 2022.
2
Diffusion Tensor Imaging Reveals Elevated Diffusivity of White Matter Microstructure that Is Independently Associated with Long-Term Outcome after Mild Traumatic Brain Injury: A TRACK-TBI Study.扩散张量成像显示,轻度创伤性脑损伤后,与长期预后相关的白质微观结构弥散度升高:TRACK-TBI 研究。
J Neurotrauma. 2022 Oct;39(19-20):1318-1328. doi: 10.1089/neu.2021.0408. Epub 2022 Jul 18.
3
Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration.小胶质细胞与神经炎症:创伤性脑损伤所致神经退行性变的关键病理机制
Front Aging Neurosci. 2022 Mar 25;14:825086. doi: 10.3389/fnagi.2022.825086. eCollection 2022.
4
GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask.胶质纤维酸性蛋白和S100B蛋白:你一直想知道却不敢问的事。
Front Neurol. 2022 Mar 21;13:835597. doi: 10.3389/fneur.2022.835597. eCollection 2022.
5
A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease.在慢性创伤性脑病和阿尔茨海默病中,tau 和淀粉样β 脑脊液生物标志物的比较。
Alzheimers Res Ther. 2022 Feb 9;14(1):28. doi: 10.1186/s13195-022-00976-y.
6
Axonal injury following mild traumatic brain injury is exacerbated by repetitive insult and is linked to the delayed attenuation of NeuN expression without concomitant neuronal death in the mouse.轻度外伤性脑损伤后的轴突损伤会因反复损伤而加重,并与小鼠中 NeuN 表达的延迟衰减而无伴随神经元死亡有关。
Brain Pathol. 2022 Mar;32(2):e13034. doi: 10.1111/bpa.13034. Epub 2021 Nov 3.
7
The Effect of Mild Traumatic Brain Injury on Cerebral Microbleeds in Aging.轻度创伤性脑损伤对老年人脑微出血的影响。
Front Aging Neurosci. 2021 Sep 30;13:717391. doi: 10.3389/fnagi.2021.717391. eCollection 2021.
8
Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project.开发在生前检测和诊断慢性创伤性脑病的方法:DIAGNOSE CTE 研究项目的基本原理、设计和方法学。
Alzheimers Res Ther. 2021 Aug 12;13(1):136. doi: 10.1186/s13195-021-00872-x.
9
Positron emission tomography imaging for the assessment of mild traumatic brain injury and chronic traumatic encephalopathy: recent advances in radiotracers.用于评估轻度创伤性脑损伤和慢性创伤性脑病的正电子发射断层扫描成像:放射性示踪剂的最新进展
Neural Regen Res. 2022 Jan;17(1):74-81. doi: 10.4103/1673-5374.314285.
10
Chronic Traumatic Encephalopathy: Update on Current Clinical Diagnosis and Management.慢性创伤性脑病:当前临床诊断与管理的最新进展
Biomedicines. 2021 Apr 12;9(4):415. doi: 10.3390/biomedicines9040415.